AGT and cardiac hypertrophy: Upon our hypothesis that miR-21 is a major regulator controlling age-associated cardiac hypertrophy, we treated aged and young cardiomyocytes with Ang II and found that, post treatment, both primarily isolated young and aged cardiomyocytes presented with hypertrophic changes.